Paratek Pharmaceuticals I... (PRTK)
NASDAQ: PRTK
· Real-Time Price · USD
2.23
0.04 (1.83%)
At close: Sep 20, 2023, 10:00 PM
Paratek Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 167.74M | 157.24M | 150.79M | 107.46M | 101.05M | 128.9M | 120.95M | 106.57M | 96.93M | 50.41M |
Cost of Revenue | 25.3M | 25.81M | 23.06M | 17.46M | 17.38M | 22.28M | 21.54M | 19.74M | 17.47M | 9.93M |
Gross Profit | 142.45M | 131.43M | 127.73M | 90M | 83.67M | 106.62M | 99.42M | 86.83M | 79.46M | 40.48M |
Operating Income | -44.54M | -48.3M | -46.21M | -70.65M | -67.88M | -40.62M | -41.13M | -31.38M | -33.61M | -66.15M |
Interest Income | 986K | 867K | 753K | 431K | 270K | 148K | 66K | 228K | 483K | 835K |
Pretax Income | -62.56M | -65.68M | -63.51M | -88.06M | -85.38M | -58.05M | -58.48M | -51.84M | -54.49M | -87.27M |
Net Income | -67.12M | -74.64M | -72.41M | -97.5M | -90.44M | -58.65M | -59.08M | -51.84M | -54.49M | -87.27M |
Selling & General & Admin | 157.41M | 151.48M | 145.6M | 135.77M | 127.88M | 124.65M | 119.4M | 99.76M | 94.71M | 88.58M |
Research & Development | 38.83M | 37.65M | 37.82M | 33.93M | 33.37M | 32.29M | 30.35M | 26.26M | 25.03M | 23.07M |
Other Expenses | -7.38M | -9.41M | -7.21M | -4.26M | -2.04M | 5K | -13K | -36K | 97K | 131K |
Operating Expenses | 186.99M | 179.73M | 173.94M | 160.65M | 151.55M | 147.24M | 140.55M | 118.21M | 113.07M | 106.63M |
Interest Expense | 18.86M | 18.12M | 18.12M | 17.95M | 17.78M | 17.58M | 17.41M | 18.28M | 19.09M | 19.72M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 212.29M | 205.54M | 197M | 178.11M | 168.93M | 169.52M | 162.08M | 137.95M | 130.54M | 116.56M |
Income Tax Expense | 4.56M | 8.96M | 8.9M | 13.84M | 9.45M | 5M | 5M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 57.28M | 56.9M | 54.39M | 55.17M | 53.02M | 52.15M | 50.63M | 49.21M | 47.12M | 46.66M |
Shares Outstanding (Diluted) | 57.28M | 56.9M | 54.39M | 55.17M | 53.02M | 52.15M | 50.63M | 49.21M | 48.95M | 46.66M |
EPS (Basic) | -1.19 | -1.36 | -1.35 | -1.86 | -1.77 | -1.15 | -1.2 | -1.1 | -1.19 | -1.92 |
EPS (Diluted) | -1.19 | -1.36 | -1.35 | -1.86 | -1.77 | -1.15 | -1.2 | -1.1 | -1.19 | -1.92 |
EBITDA | -43.4M | -47.17M | -44.9M | -69.63M | -67.16M | -40.04M | -40.69M | -30.88M | -32.63M | -64.7M |
EBIT | -43.71M | -47.56M | -45.39M | -70.11M | -67.6M | -40.47M | -41.08M | -33.56M | -35.4M | -67.55M |
Depreciation & Amortization | 949K | 1.13M | 1.03M | 724K | 536K | 425K | 391K | 454K | 539K | 618K |